Predictors of first recurrence of Clostridium difficile infections in children

Sarah Tschudin-Sutter1, Pranita D Tamma, Aaron M Milstone

  • 1From the *Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine; †Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; and ‡Department of Pediatrics, Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD.

Insights

Recurrent Clostridium difficile infection (CDI) affects 12% of hospitalized children. Concomitant antibiotics and community-associated CDI increase this risk, suggesting careful antibiotic stewardship is crucial for pediatric patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Clinical Epidemiology

Background:

  • Clostridium difficile infection (CDI) is a significant cause of healthcare-associated diarrhea in children.
  • Data on the incidence and risk factors for CDI recurrence in pediatric populations remain limited.
  • Understanding recurrence patterns is essential for optimizing treatment and prevention strategies.

Purpose of the Study:

  • To investigate the risk and identify independent predictors of recurrent Clostridium difficile infection in hospitalized children.
  • To inform clinical practice regarding antibiotic use in pediatric CDI cases.

Main Methods:

  • A retrospective cohort study was conducted over a 9-year period.
  • Hospitalized children diagnosed with CDI were identified and followed for recurrence.
  • Statistical analysis was performed to determine factors associated with recurrent CDI.

Main Results:

  • The overall rate of recurrent CDI in hospitalized children was 12% over the 9-year study period.
  • Concomitant antibiotic use (antibiotics prescribed for indications other than CDI) was independently associated with increased risk of recurrence.
  • Community-associated CDI also emerged as an independent risk factor for recurrence in this cohort.

Conclusions:

  • Recurrence of Clostridium difficile infection is a notable concern in hospitalized children, occurring in 12% of cases.
  • The findings highlight the critical role of concomitant antibiotic exposure and initial community acquisition as significant risk factors for CDI recurrence in pediatric patients.
  • Discontinuation of non-CDI-related antibiotics should be strongly considered to mitigate recurrence risk.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
73
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
75
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.1K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K